2020
DOI: 10.1101/2020.05.11.088724
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Rapid, Cost-Effective Tailed Amplicon Method for Sequencing SARS-CoV-2

Abstract: The global COVID-19 pandemic has led to an urgent need for scalable methods for clinical diagnostics and viral tracking. Next generation sequencing technologies have enabled largescale genomic surveillance of SARS-CoV-2 as thousands of isolates are being sequenced around the world and deposited in public data repositories. A number of methods using both short-and long-read technologies are currently being applied for SARS-CoV-2 sequencing, including amplicon approaches, metagenomic methods, and sequence captur… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
20
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(23 citation statements)
references
References 21 publications
3
20
0
Order By: Relevance
“…We adopted amplicon-based sequencing (amplicon-seq), a method widely used to characterize SARS-CoV-2 genomes 25 , to characterize the presence of sgRNAs and correlate their abundance in the COVID-19 positive samples between symptomatic and asymptomatic patients. Ampliconseq is highly sensitive, with limit of detection (LoD) reported as low as one SARS-CoV-2 copy per microliter using the optimized protocols from the Artic network 26,27 . Therefore, it can effectively enrich for SARS-CoV-2 cDNAs from samples of wide-range of viral content.…”
Section: Sgrna Expression Is Drastically Repressed In Asymptomatic Samentioning
confidence: 99%
“…We adopted amplicon-based sequencing (amplicon-seq), a method widely used to characterize SARS-CoV-2 genomes 25 , to characterize the presence of sgRNAs and correlate their abundance in the COVID-19 positive samples between symptomatic and asymptomatic patients. Ampliconseq is highly sensitive, with limit of detection (LoD) reported as low as one SARS-CoV-2 copy per microliter using the optimized protocols from the Artic network 26,27 . Therefore, it can effectively enrich for SARS-CoV-2 cDNAs from samples of wide-range of viral content.…”
Section: Sgrna Expression Is Drastically Repressed In Asymptomatic Samentioning
confidence: 99%
“…Several approaches have been used to sequence the SARS-CoV-2 genome, including metagenomics (Manning et al 2020) , sequence capture (Gohl et al 2020) , SISPA (Moore et al 2020) , and multiplex PCR (Gohl et al 2020;Itokawa et al 2020;Resende et al 2020;Moore et al 2020;Eden et al 2020) , followed by next generation sequencing using either the Illumina or Oxford Nanopore platforms. Due to its simplicity and economy, using multiplexed PCR amplicons is perhaps the most common approach.…”
Section: Introductionmentioning
confidence: 99%
“…In a recent paper, Kim et al [3] explored the transcriptomic architecture of SARS-CoV-2 by performing short-read as well as long-read sequencing of Vero cells infected by the virus. The authors used oligo(dT) amplification, which targets the poly(A) tail at the 3’ end of messenger RNAs, thus limiting positional bias that would occur when using SARS-CoV-2 specific primers [25, 26]. Subsequently, the authors aligned the resulting reads using splice-aware aligners, i.e.…”
Section: Resultsmentioning
confidence: 99%